URL | Priority | Change frequency | Last modified (GMT) |
---|---|---|---|
https://astx.com/2018-ash-long-term-results-of-a-randomized-phase-2-dose-response-study-of-guadecitabine-a-novel-subcutaneous-sc-hypomethylating-agent-hma-in-102-patients-with-intermediate-or-high-risk-myelodys/ | 20% | Monthly | 2019-07-15 07:25 |